Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
All content curated by
featured
Published in Eye Care

Journal Scan / Research · September 08, 2024

Association Between GLP-1RA Use and the Risk of Glaucoma in Individuals With Type 2 Diabetes

Ophthalmology

 

Additional Info

Ophthalmology
Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes
Ophthalmology 2024 Sep 01;131(9)1056-1063, S Niazi, F Gnesin, AS Thein, JR Andreasen, A Horwitz, ZA Mouhammad, BN Jawad, Z Niazi, N Pourhadi, B Zareini, A Meaidi, C Torp-Pedersen, M Kolko

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading